SCHEMBL1993379

SCHEMBL1993379

COCc1cc(-c2ccccc2)c(C(=O)C(=O)O)n1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.40
GABRG2 P18507 2/20 0.40
GABRB3 P28472 2/20 0.40
GABRA3 P34903 2/20 0.40
ASH1L Q9NR48 1/20 0.39
THRB P10828 1/20 0.37
KDM4E B2RXH2 6/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP2C19 P33261 1/20 0.36
EGFR P00533 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA2 P47869 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1127705 0.85 KDM4E (0.36) GABRA1GABRG2GABRB3GABRA3ASH1L
SCHEMBL16500197 0.73 ALDH1A1 (0.44) GABRA1GABRG2GABRB3GABRA3KDM4E
SCHEMBL1127204 0.72 THRB (0.40) GABRA1GABRG2GABRB3GABRA3THRB
SCHEMBL15162338 0.72 ALDH1A1 (0.43) THRBKDM4ESMN1; SMN2CYP2C19L3MBTL1
SCHEMBL24584645 0.72 PGR (0.43) KDM4ESMN1; SMN2L3MBTL1ALDH1A1GAA
SCHEMBL1126650 0.70 THRB (0.41) GABRA1GABRG2GABRB3GABRA3THRB
SCHEMBL31585967 0.69 SMN1; SMN2 (0.39) GABRA1GABRG2GABRB3GABRA3THRB
SCHEMBL15161896 0.69 CNR1 (0.38) GABRA1GABRG2GABRB3GABRA3THRB
SCHEMBL31585835 0.68 GABRA1 (0.45) GABRA1GABRG2GABRB3GABRA3THRB
SCHEMBL15162319 0.67 THRB (0.36) GABRA1GABRG2GABRB3GABRA3THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9452168-B2 Pyrrole antifungal agents F2G LTD (GB) 2016-09-27 US disclosed
US-20150238500-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2015-08-27 US disclosed
US-8993574-B2 Pyrrole antifungal agents F2G LTD (GB) 2015-03-31 US disclosed
EP-2283006-B1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2015-02-25 EP disclosed
EP-2626361-B1 Pyrrole antifungal agents F2G LTD (GB) 2014-10-15 EP disclosed
EP-2626361-A1 Pyrrole antifungal agents F2G Limited (GB) 2013-08-14 EP disclosed
US-20110152285-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152285-A1 PYRROLE ANTIFUNGAL AGENTS FOXM1, PYCR1, ARG1 GABRA1 2376/4885GABRG2 3178/4885GABRB3 3803/4885
US-20150238500-A1 PYRROLE ANTIFUNGAL AGENTS FOXM1, PYCR1, ARG1 GABRA1 2376/4885GABRG2 3178/4885GABRB3 3803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.